39. Chroneos Z, Shepherd VL (1995) Differential regulation of the mannose and SP-A receptors on macrophages. Am J Physiol 269: L721–L726. 40. Hogger P, Dreier J, Droste A, Buck F, Sorg C (1998) Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid- inducible member of the scavenger receptor cysteine-rich family (CD163). J Immunol 161: 1883–1890. 41. Koning N, van Eijk M, Pouwels W, Brouwer MS, Voehringer D, et al. (2010) Expression of the inhibitory CD200 receptor is associated with alternative macrophage activation. J Innate Immun 2: 195–200. 000252803 [pii];10.1159/ 000252803 [doi]. 42. Mathsson L, Lampa J, Mullazehi M, Ronnelid J (2006) Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells. Arthritis Res Ther 8: R64. ar1926 [pii];10.1186/ar1926 [doi]. 43. Ravetch JV, Bolland S (2001) IgG Fc receptors. Annu Rev Immunol 19: 275–290. 19/1/275 [pii];10.1146/annurev.immunol.19.1.275 [doi]. 44. Wenink MH, Santegoets KC, Roelofs MF, Huijbens R, Koenen HJ, et al. (2009) The inhibitory Fc gamma IIb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent disease. J Immunol 183: 4509–4520. jimmunol.0900153 [pii];10.4049/jimmunol.0900153 [doi]. 45. Wernersson S, Karlsson MC, Dahlstrom J, Mattsson R, Verbeek JS, et al. (1999) IgG-mediated enhancement of antibody responses is low in Fc receptor gamma chain-deficient mice and increased in Fc gamma RII-deficient mice. J Immunol 163: 618–622. ji_v163n2p618 [pii]. 46. Kim JW, Wierda WG, Kim YB (1991) Immobilized IgG immune complex induces secretion of tumor necrosis factor-alpha by porcine alveolar macro- phages. Am J Respir Cell Mol Biol 5: 249–255. 47. Gupta S, Booth JW (2010) ERK phosphorylation and tumor necrosis factor- alpha production by monocytes are persistent in response to immobilized IgG. Biochem Biophys Res Commun 402: 301–304. S0006-291X(10)01871-1 [pii];10.1016/j.bbrc.2010.10.020 [doi]. 48. DiMartino SJ, Yuan W, Redecha P, Ivashkiv LB, Salmon JE (2008) Insoluble immune complexes are most effective at triggering IL-10 production in human Effect of Immune Complexes on Macrophage Subsets monocytes and synergize with TLR ligands and C5a. Clin Immunol 127: 56–65. S1521-6616(07)01413-1 [pii];10.1016/j.clim.2007.11.014 [doi]. 49. Boross P, Verbeek JS (2006) The complex role of Fcgamma receptors in the pathology of arthritis. Springer Semin Immunopathol 28: 339–350. 10.1007/ s00281-006-0049-9 [doi]. 50. Ji JD, Tassiulas I, Park-Min KH, Aydin A, Mecklenbrauker I, et al. (2003) Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis. J Exp Med 197: 1573–1583. 10.1084/jem.20021820 [doi];jem.20021820 [pii]. 51. Yuan W, DiMartino SJ, Redecha PB, Ivashkiv LB, Salmon JE (2011) Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes. Arthritis Rheum 63: 212–218. 10.1002/ art.30083 [doi]. 52. Ballow M (2011) The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J Allergy Clin Immunol 127: 315–323. S0091- 6749(10)01645-3 [pii];10.1016/j.jaci.2010.10.030 [doi]. 53. Ephrem A, Misra N, Hassan G, Dasgupta S, Delignat S, et al. (2005) Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin. Clin Exp Med 5: 135–140. 10.1007/s10238-005-0079-y [doi]. 54. Nimmerjahn F, Ravetch JV (2007) Fc-receptors as regulators of immunity. Adv Immunol 96: 179–204. S0065-2776(07)96005-8 [pii];10.1016/S0065- 2776(07)96005-8 [doi]. 55. Nimmerjahn F, Ravetch JV (2007) The antiinflammatory activity of IgG: the intravenous IgG paradox. J Exp Med 204: 11–15. jem.20061788 [pii];10.1084/ jem.20061788 [doi]. 56. Vos AC, Wildenberg ME, Duijvestein M, Verhaar AP, van den Brink GR, et al. (2011) Anti-tumor necrosis factor-alpha antibodies induce regulatory macro- phages in an Fc region-dependent manner. Gastroenterology 140: 221–230. S0016-5085(10)01496-4 [pii];10.1053/j.gastro.2010.10.008 [doi]. 57. Vos AC, Wildenberg ME, Arijs I, Duijvestein M, Verhaar AP, et al. (2011) Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro. Inflamm Bowel Dis 10.1002/ibd.21818 [doi]. PLoS ONE | www.plosone.org 10 April 2012 | Volume 7 | Issue 4 | e35994